Hormone Solutions Update December 2014
Dear Dr Customer
With the end of 2014 just around the corner it is time to reflect on what a busy year it has been for Lawley Pharmaceuticals.
In May we exhibited at the 14th World Menopause Congress in Mexico. AndroFeme received a huge amount of positive feedback from doctors attending the congress for being the worlds only clinically trialled, safe, effective and regulated testosterone cream for women. Australia leads the way in testosterone research for women and the world congress provided a fantastic forum to share our knowledge and experience.
Several important guidelines and reviews were released during 2014. The first, a review of testosterone use in men by the European Medicines Agency, found that correctly prescribed testosterone does not increase the risk of heart issues. This review was called for after negative press appeared in late 2013 and earlier this year. In fact it is widely acknowledged that men with low testosterone may have an incresed risk of heart disease and diabetes, the full article can be found below.
Guidelines for the use of testosterone for women were published from two sources in 2014, the first in the journal Climacteric, 'A Practitioner's Toolkit For Managing The Menopause', the second from the Endocrine Society. Both these guidelines give doctors clear clinical stragies to manage women with low libido and/or low testosterone.
Please also note that we have had a change to our online ordering address, see below for more details.
I wish you all a safe and happy Christmas and New Year, and as always, if you have any questions feel free to contact me directly via email at
CEO / Medical Director / Pharmacist